ID   UAP1_HUMAN              Reviewed;         522 AA.
AC   Q16222; B2R6R8; Q5VTA9; Q5VTB0; Q5VTB1; Q96GM2;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 3.
DT   15-MAR-2017, entry version 170.
DE   RecName: Full=UDP-N-acetylhexosamine pyrophosphorylase;
DE   AltName: Full=Antigen X;
DE            Short=AGX;
DE   AltName: Full=Sperm-associated antigen 2;
DE   Includes:
DE     RecName: Full=UDP-N-acetylgalactosamine pyrophosphorylase;
DE              EC=2.7.7.83;
DE     AltName: Full=AGX-1;
DE   Includes:
DE     RecName: Full=UDP-N-acetylglucosamine pyrophosphorylase;
DE              EC=2.7.7.23;
DE     AltName: Full=AGX-2;
GN   Name=UAP1; Synonyms=SPAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS AGX1; AGX2 AND 3).
RC   TISSUE=Testis;
RX   PubMed=8025165; DOI=10.1095/biolreprod50.5.1087;
RA   Diekman A.B., Goldberg E.;
RT   "Characterization of a human antigen with sera from infertile
RT   patients.";
RL   Biol. Reprod. 50:1087-1093(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AGX1).
RC   TISSUE=Testis;
RX   PubMed=9603950; DOI=10.1074/jbc.273.23.14392;
RA   Mio T., Yabe T., Arisawa M., Yamada-Okabe H.;
RT   "The eukaryotic UDP-N-acetylglucosamine pyrophosphorylases: gene
RT   cloning, protein expression, and catalytic mechanism.";
RL   J. Biol. Chem. 273:14392-14397(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM AGX1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS AGX1; AGX2 AND
RP   3).
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM AGX1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, ALTERNATIVE SPLICING, CATALYTIC ACTIVITY,
RP   AND CHARACTERIZATION.
RC   TISSUE=Mammary cancer;
RX   PubMed=9765219; DOI=10.1074/jbc.273.42.27055;
RA   Wang-Gillam A., Pastuszak I., Elbein A.D.;
RT   "A 17-amino acid insert changes UDP-N-acetylhexosamine
RT   pyrophosphorylase specificity from UDP-GalNAc to UDP-GlcNAc.";
RL   J. Biol. Chem. 273:27055-27057(1998).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATE.
RX   PubMed=11707391; DOI=10.1093/emboj/20.22.6191;
RA   Peneff C., Ferrari P., Charrier V., Taburet Y., Monnier C.,
RA   Zamboni V., Winter J., Harnois M., Fassy F., Bourne Y.;
RT   "Crystal structures of two human pyrophosphorylase isoforms in
RT   complexes with UDPGlc(Gal)NAc: role of the alternatively spliced
RT   insert in the enzyme oligomeric assembly and active site
RT   architecture.";
RL   EMBO J. 20:6191-6202(2001).
CC   -!- FUNCTION: Converts UTP and GlcNAc-1-P into UDP-GlcNAc, and UTP and
CC       GalNAc-1-P into UDP-GalNAc. Isoform AGX1 has 2 to 3 times higher
CC       activity towards GalNAc-1-P, while isoform AGX2 has 8 times more
CC       activity towards GlcNAc-1-P.
CC   -!- CATALYTIC ACTIVITY: UTP + N-acetyl-alpha-D-galactosamine 1-
CC       phosphate = diphosphate + UDP-N-acetyl-alpha-D-galactosamine.
CC       {ECO:0000269|PubMed:9765219}.
CC   -!- CATALYTIC ACTIVITY: UTP + N-acetyl-alpha-D-glucosamine 1-phosphate
CC       = diphosphate + UDP-N-acetyl-alpha-D-glucosamine.
CC       {ECO:0000269|PubMed:9765219}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; UDP-N-acetyl-alpha-D-glucosamine from N-
CC       acetyl-alpha-D-glucosamine 1-phosphate: step 1/1.
CC   -!- SUBUNIT: Monomer and homodimer. Isoform AGX1 is a homodimer.
CC       Isoform AGX2 is a monomer. {ECO:0000269|PubMed:11707391}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-10237564, EBI-10237564;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=In spermatozoa, localized to
CC       the principal piece of the tail, the neck region of the head and
CC       to a lesser extent, the midpiece of the tail.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=AGX2; Synonyms=AGX-2;
CC         IsoId=Q16222-1; Sequence=Displayed;
CC       Name=AGX1; Synonyms=AGX-1;
CC         IsoId=Q16222-2; Sequence=VSP_004483;
CC       Name=3;
CC         IsoId=Q16222-3; Sequence=VSP_014523;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform AGX1 is more
CC       abundant in testis than isoform AGX2, while isoform AGX2 is more
CC       abundant than isoform AGX1 in somatic tissue. Expressed at low
CC       level in placenta, muscle and liver.
CC   -!- SIMILARITY: Belongs to the UDPGP type 1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S73498; AAB31210.2; -; mRNA.
DR   EMBL; AB011004; BAA31202.1; -; mRNA.
DR   EMBL; AK312685; BAG35565.1; -; mRNA.
DR   EMBL; AL596325; CAH72978.1; -; Genomic_DNA.
DR   EMBL; AL596325; CAH72979.1; -; Genomic_DNA.
DR   EMBL; AL596325; CAH72980.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90710.1; -; Genomic_DNA.
DR   EMBL; BC009377; AAH09377.1; -; mRNA.
DR   CCDS; CCDS1240.1; -. [Q16222-2]
DR   CCDS; CCDS81393.1; -. [Q16222-1]
DR   CCDS; CCDS81394.1; -. [Q16222-3]
DR   RefSeq; NP_001311042.1; NM_001324113.1. [Q16222-2]
DR   RefSeq; NP_001311043.1; NM_001324114.1. [Q16222-2]
DR   RefSeq; NP_001311044.1; NM_001324115.1. [Q16222-2]
DR   RefSeq; NP_001311045.1; NM_001324116.1. [Q16222-1]
DR   RefSeq; NP_001311046.1; NM_001324117.1. [Q16222-3]
DR   RefSeq; NP_003106.3; NM_003115.4. [Q16222-2]
DR   RefSeq; XP_011508215.1; XM_011509913.2. [Q16222-1]
DR   RefSeq; XP_011508216.1; XM_011509914.2. [Q16222-1]
DR   UniGene; Hs.492859; -.
DR   PDB; 1JV1; X-ray; 1.90 A; A/B=1-522.
DR   PDB; 1JV3; X-ray; 2.20 A; A/B=1-522.
DR   PDB; 1JVD; X-ray; 2.40 A; A/B=1-522.
DR   PDB; 1JVG; X-ray; 2.30 A; A/B=1-522.
DR   PDBsum; 1JV1; -.
DR   PDBsum; 1JV3; -.
DR   PDBsum; 1JVD; -.
DR   PDBsum; 1JVG; -.
DR   DisProt; DP00363; -.
DR   ProteinModelPortal; Q16222; -.
DR   SMR; Q16222; -.
DR   BioGrid; 112557; 20.
DR   IntAct; Q16222; 7.
DR   STRING; 9606.ENSP00000356903; -.
DR   DrugBank; DB02196; Uridine-Diphosphate-N-Acetylgalactosamine.
DR   DrugBank; DB03397; Uridine-Diphosphate-N-Acetylglucosamine.
DR   iPTMnet; Q16222; -.
DR   PhosphoSitePlus; Q16222; -.
DR   BioMuta; UAP1; -.
DR   DMDM; 68846235; -.
DR   REPRODUCTION-2DPAGE; IPI00217816; -.
DR   EPD; Q16222; -.
DR   MaxQB; Q16222; -.
DR   PaxDb; Q16222; -.
DR   PeptideAtlas; Q16222; -.
DR   PRIDE; Q16222; -.
DR   Ensembl; ENST00000271469; ENSP00000271469; ENSG00000117143. [Q16222-1]
DR   Ensembl; ENST00000367924; ENSP00000356901; ENSG00000117143. [Q16222-3]
DR   Ensembl; ENST00000367925; ENSP00000356902; ENSG00000117143. [Q16222-1]
DR   Ensembl; ENST00000367926; ENSP00000356903; ENSG00000117143. [Q16222-2]
DR   GeneID; 6675; -.
DR   KEGG; hsa:6675; -.
DR   UCSC; uc001gce.5; human. [Q16222-1]
DR   CTD; 6675; -.
DR   DisGeNET; 6675; -.
DR   GeneCards; UAP1; -.
DR   H-InvDB; HIX0001264; -.
DR   HGNC; HGNC:12457; UAP1.
DR   HPA; HPA014659; -.
DR   MIM; 602862; gene.
DR   neXtProt; NX_Q16222; -.
DR   OpenTargets; ENSG00000117143; -.
DR   PharmGKB; PA37107; -.
DR   eggNOG; KOG2388; Eukaryota.
DR   eggNOG; COG4284; LUCA.
DR   GeneTree; ENSGT00390000010072; -.
DR   HOGENOM; HOG000186273; -.
DR   HOVERGEN; HBG018024; -.
DR   InParanoid; Q16222; -.
DR   KO; K00972; -.
DR   OMA; YAGENLV; -.
DR   OrthoDB; EOG091G05FO; -.
DR   PhylomeDB; Q16222; -.
DR   TreeFam; TF300611; -.
DR   BRENDA; 2.7.7.83; 2681.
DR   Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   SABIO-RK; Q16222; -.
DR   UniPathway; UPA00113; UER00533.
DR   ChiTaRS; UAP1; human.
DR   EvolutionaryTrace; Q16222; -.
DR   GeneWiki; UAP1; -.
DR   GenomeRNAi; 6675; -.
DR   PRO; PR:Q16222; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117143; -.
DR   CleanEx; HS_UAP1; -.
DR   ExpressionAtlas; Q16222; baseline and differential.
DR   Genevisible; Q16222; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003977; F:UDP-N-acetylglucosamine diphosphorylase activity; IBA:GO_Central.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR002618; UDPGP_fam.
DR   Pfam; PF01704; UDPGP; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Nucleotidyltransferase; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    522       UDP-N-acetylhexosamine pyrophosphorylase.
FT                                /FTId=PRO_0000185767.
FT   REGION      108    111       UTP binding.
FT                                {ECO:0000250|UniProtKB:Q9M9P3}.
FT   MOTIF       108    111       Substrate binding.
FT   MOTIF       303    304       Substrate binding.
FT   BINDING     122    122       UTP. {ECO:0000250|UniProtKB:Q9M9P3}.
FT   BINDING     196    196       UTP. {ECO:0000250|UniProtKB:Q9M9P3}.
FT   BINDING     222    222       UTP; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:Q9M9P3}.
FT   BINDING     223    223       Substrate. {ECO:0000269|PubMed:11707391}.
FT   BINDING     253    253       UTP. {ECO:0000250|UniProtKB:Q9M9P3}.
FT   BINDING     377    377       UTP. {ECO:0000250|UniProtKB:Q9M9P3}.
FT   BINDING     407    407       Substrate. {ECO:0000269|PubMed:11707391}.
FT   VAR_SEQ     454    470       Missing (in isoform AGX1).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8025165,
FT                                ECO:0000303|PubMed:9603950}.
FT                                /FTId=VSP_004483.
FT   VAR_SEQ     454    454       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:8025165}.
FT                                /FTId=VSP_014523.
FT   VARIANT     418    418       P -> H (in dbSNP:rs1128539).
FT                                /FTId=VAR_014935.
FT   CONFLICT     61     61       H -> Y (in Ref. 6; AAH09377).
FT                                {ECO:0000305}.
FT   CONFLICT    445    445       G -> S (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    454    454       S -> Q (in Ref. 1 and 2). {ECO:0000305}.
FT   HELIX         3     12       {ECO:0000244|PDB:1JV1}.
FT   HELIX        16     19       {ECO:0000244|PDB:1JV1}.
FT   HELIX        22     24       {ECO:0000244|PDB:1JV1}.
FT   HELIX        27     38       {ECO:0000244|PDB:1JV1}.
FT   HELIX        42     54       {ECO:0000244|PDB:1JV1}.
FT   HELIX        74     76       {ECO:0000244|PDB:1JV1}.
FT   STRAND       77     79       {ECO:0000244|PDB:1JV1}.
FT   TURN         80     83       {ECO:0000244|PDB:1JV1}.
FT   HELIX        84     86       {ECO:0000244|PDB:1JV1}.
FT   HELIX        87     99       {ECO:0000244|PDB:1JV1}.
FT   STRAND      103    108       {ECO:0000244|PDB:1JV1}.
FT   HELIX       114    116       {ECO:0000244|PDB:1JVG}.
FT   HELIX       122    124       {ECO:0000244|PDB:1JV1}.
FT   HELIX       135    154       {ECO:0000244|PDB:1JV1}.
FT   STRAND      162    166       {ECO:0000244|PDB:1JV1}.
FT   TURN        168    170       {ECO:0000244|PDB:1JV1}.
FT   HELIX       171    180       {ECO:0000244|PDB:1JV1}.
FT   HELIX       181    185       {ECO:0000244|PDB:1JV1}.
FT   HELIX       188    190       {ECO:0000244|PDB:1JV1}.
FT   STRAND      191    195       {ECO:0000244|PDB:1JV1}.
FT   STRAND      198    200       {ECO:0000244|PDB:1JV1}.
FT   STRAND      210    212       {ECO:0000244|PDB:1JV1}.
FT   STRAND      218    220       {ECO:0000244|PDB:1JV1}.
FT   HELIX       223    225       {ECO:0000244|PDB:1JV1}.
FT   HELIX       226    232       {ECO:0000244|PDB:1JV1}.
FT   HELIX       235    241       {ECO:0000244|PDB:1JV1}.
FT   STRAND      246    251       {ECO:0000244|PDB:1JV1}.
FT   HELIX       262    270       {ECO:0000244|PDB:1JV1}.
FT   STRAND      274    281       {ECO:0000244|PDB:1JV1}.
FT   STRAND      291    295       {ECO:0000244|PDB:1JV1}.
FT   STRAND      298    302       {ECO:0000244|PDB:1JV1}.
FT   HELIX       304    306       {ECO:0000244|PDB:1JV1}.
FT   HELIX       309    313       {ECO:0000244|PDB:1JV1}.
FT   STRAND      319    323       {ECO:0000244|PDB:1JV1}.
FT   STRAND      325    334       {ECO:0000244|PDB:1JV1}.
FT   HELIX       335    343       {ECO:0000244|PDB:1JV1}.
FT   HELIX       346    348       {ECO:0000244|PDB:1JV1}.
FT   STRAND      352    356       {ECO:0000244|PDB:1JV1}.
FT   STRAND      375    379       {ECO:0000244|PDB:1JV1}.
FT   HELIX       382    388       {ECO:0000244|PDB:1JV1}.
FT   STRAND      390    397       {ECO:0000244|PDB:1JV1}.
FT   HELIX       399    402       {ECO:0000244|PDB:1JV1}.
FT   STRAND      412    417       {ECO:0000244|PDB:1JV1}.
FT   HELIX       418    435       {ECO:0000244|PDB:1JV1}.
FT   STRAND      439    441       {ECO:0000244|PDB:1JV1}.
FT   STRAND      481    483       {ECO:0000244|PDB:1JV1}.
FT   TURN        485    487       {ECO:0000244|PDB:1JV1}.
FT   STRAND      489    491       {ECO:0000244|PDB:1JV1}.
FT   HELIX       495    498       {ECO:0000244|PDB:1JV1}.
FT   STRAND      505    510       {ECO:0000244|PDB:1JV1}.
FT   STRAND      513    516       {ECO:0000244|PDB:1JV1}.
SQ   SEQUENCE   522 AA;  58769 MW;  8A69B36D852B9472 CRC64;
     MNINDLKLTL SKAGQEHLLR FWNELEEAQQ VELYAELQAM NFEELNFFFQ KAIEGFNQSS
     HQKNVDARME PVPREVLGSA TRDQDQLQAW ESEGLFQISQ NKVAVLLLAG GQGTRLGVAY
     PKGMYDVGLP SRKTLFQIQA ERILKLQQVA EKYYGNKCII PWYIMTSGRT MESTKEFFTK
     HKYFGLKKEN VIFFQQGMLP AMSFDGKIIL EEKNKVSMAP DGNGGLYRAL AAQNIVEDME
     QRGIWSIHVY CVDNILVKVA DPRFIGFCIQ KGADCGAKVV EKTNPTEPVG VVCRVDGVYQ
     VVEYSEISLA TAQKRSSDGR LLFNAGNIAN HFFTVPFLRD VVNVYEPQLQ HHVAQKKIPY
     VDTQGQLIKP DKPNGIKMEK FVFDIFQFAK KFVVYEVLRE DEFSPLKNAD SQNGKDNPTT
     ARHALMSLHH CWVLNAGGHF IDENGSRLPA IPRSATNGKS ETITADVNHN LKDANDVPIQ
     CEISPLISYA GEGLESYVAD KEFHAPLIID ENGVHELVKN GI
//
